Sources and provenance
Original guidance, trials, reviews, lived accounts and regulatory records. Access scope is explicit; these organizations do not endorse Brighter Postpartum.
Research preview · selected sources rechecked September 14, 2026 · independent clinical review pending. These editorial assessments are not formal GRADE ratings. No study here establishes an effect of Brighter Postpartum.
- S01
Perinatal Depression ↗Final pass: original page or abstract rechecked; not a new systematic review.
- S02
Perinatal Depression: Preventive Interventions ↗Current final recommendation retrieved; update in progress is not a new final recommendation.
Final pass: original page or abstract rechecked; not a new systematic review.
- S03
Interventions to Prevent Perinatal Depression: Evidence Report and Systematic Review ↗2026-09-14 primary-source recheck.
- S04
Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: Clinical Practice Guideline No. 4 ↗Carried forward from prior research pass; see recorded access scope.
- S05
Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum: Clinical Practice Guideline No. 5 ↗2026-09-14 primary-source recheck.
- S06
Timing of Postpartum Depressive Symptoms ↗Seven-state PRAMS follow-up, not a current national prevalence estimate.
2026-09-14 primary-source recheck.
- S07
Environmental risk factors, protective factors, and biomarkers for postpartum depressive symptoms: an umbrella review ↗2026-09-14 primary-source recheck.
- S08
Postpartum depression risk-factor umbrella review ↗DOI 10.3389/fpubh.2025.1714668; publication in 2026. Most underlying certainty low or very low.
Carried forward from prior research pass; see recorded access scope.
- S09
Effects of gonadal steroids in women with a history of postpartum depression ↗Final pass: original page or abstract rechecked; not a new systematic review.
- S10
Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history ↗Administrative treatment/contact definition misses untreated depression.
Carried forward from prior research pass; see recorded access scope.
- S11
Effect of peer support on prevention of postnatal depression among high risk women ↗2026-09-14 primary-source recheck.
- S12
Randomized controlled trial to prevent postpartum depression in mothers on public assistance ↗Carried forward from prior research pass; see recorded access scope.
- S13
Anxiety-focused cognitive behavioral therapy delivered by non-specialists to prevent postnatal depression ↗Happy Mother–Healthy Baby, Pakistan. Attrition and setting limit transferability.
Carried forward from prior research pass; see recorded access scope.
- S14
Task-sharing and telemedicine delivery of psychotherapy to treat perinatal depression: a pragmatic randomized noninferiority trial ↗SUMMIT; trained and supervised people, not autonomous AI.
2026-09-14 primary-source recheck.
- S15
Technology-assisted peer-delivered psychological intervention for perinatal depression ↗THP-TAP, Pakistan; compare with established Thinking Healthy Programme.
Carried forward from prior research pass; see recorded access scope.
- S16
Internet-based cognitive behavioral therapy for prevention of depression during pregnancy and in the postpartum period ↗Overall primary result negative; favorable subgroup was post hoc. Erratum exists.
2026-09-14 primary-source recheck.
- S17
Randomized controlled trial of digital cognitive behavior therapy for prenatal insomnia: postpartum outcomes ↗2026-09-14 primary-source recheck.
- S18
Impact of postpartum physical activity on maternal depression and anxiety: systematic review and meta-analysis ↗Online publication 2024; 2025 issue. High heterogeneity for depressive symptoms.
2026-09-14 primary-source recheck.
- S19
Aerobic exercise and postpartum depression: dose-response systematic review and meta-analysis ↗Carried forward from prior research pass; see recorded access scope.
- S20
Effects of online mindfulness interventions on perinatal mental health ↗Carried forward from prior research pass; see recorded access scope.
- S21
Mindfulness interventions and postpartum depression: systematic review and meta-analysis ↗Contrasting, nonsignificant pooled EPDS result; retain alongside positive reviews.
Carried forward from prior research pass; see recorded access scope.
- S22
Yoga for postpartum depression: a randomized controlled trial ↗Carried forward from prior research pass; see recorded access scope.
- S23
Expressive writing in the postpartum period: randomized controlled trial ↗Carried forward from prior research pass; see recorded access scope.
- S24
Religiosity, spirituality, and postpartum depressive symptoms ↗Observational religious participation is not a randomized test of prayer.
Carried forward from prior research pass; see recorded access scope.
- S25
Neurolinguistic programming: a systematic review of the effects on health outcomes ↗Carried forward from prior research pass; see recorded access scope.
- S26
Vitamin D and postpartum depressive symptoms: systematic review and meta-analysis ↗Only two randomized trials in pooled supplementation estimate; low certainty.
2026-09-14 primary-source recheck.
- S27
Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children ↗DOMInO trial; prevention result not statistically significant.
2026-09-14 primary-source recheck.
- S28
Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety ↗Mood secondary to infant-eczema trial; strain-specific, modified questionnaires.
Carried forward from prior research pass; see recorded access scope.
- S29
Effects of zinc and magnesium supplements on postpartum depression and anxiety: a randomized controlled trial ↗Neither mineral improved symptoms relative to placebo in this trial.
2026-09-14 primary-source recheck.
- S30
Dietary supplement for mood symptoms in early postpartum: a double-blind randomized placebo controlled trial ↗Primary outcome negative; exploratory baby-blues result positive. Inventor patents and CAMH/Exeltis funding disclosed.
Carried forward from prior research pass; see recorded access scope.
- S31
Placentophagy effects on mood, bonding, and fatigue: a pilot trial ↗Small pilot, no robust between-group benefits.
Carried forward from prior research pass; see recorded access scope.
- S32
Late-Onset Infant Group B Streptococcus Infection Associated with Maternal Consumption of Capsules Containing Dehydrated Placenta ↗Carried forward from prior research pass; see recorded access scope.
- S33
Theanine ↗Carried forward from prior research pass; see recorded access scope.
- S34
Bright light therapy for perinatal depression: randomized pilot trial ↗Mixed pregnant/postpartum sample of 22; not a test of ordinary sunlight.
Carried forward from prior research pass; see recorded access scope.
- S35
A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression ↗38 participants; small trial.
Carried forward from prior research pass; see recorded access scope.
- S36
Prevention of postpartum depression: a pilot randomized clinical trial ↗22 women with prior postpartum depression; not universal prophylaxis.
Carried forward from prior research pass; see recorded access scope.
- S37
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial ↗Phase 3 earlier formulation; follow-up to day 45, not proof of permanent cure.
Carried forward from prior research pass; see recorded access scope.
- S38
FDA Approves First Oral Treatment for Postpartum Depression ↗Carried forward from prior research pass; see recorded access scope.
- S39
Withdrawal of Approval of ZULRESSO (Brexanolone), effective April 14, 2025 ↗Manufacturer reported product no longer marketed and requested withdrawal.
Carried forward from prior research pass; see recorded access scope.
- S40
Postpartum psychosis ↗2026-09-14 primary-source recheck.
- S41
Postpartum Thoughts of Infant-Related Harm and OCD: Relation to Maternal Physical Aggression Toward the Infant ↗Carried forward from prior research pass; see recorded access scope.
- S42
Thyroid Disease and Pregnancy: Postpartum Thyroiditis ↗Carried forward from prior research pass; see recorded access scope.
- S43
Evaluating the Efficacy of MamaLift Plus (SuMMER): Randomized, Placebo-Controlled Pivotal Trial ↗Industry-affiliated authors; symptom improvement endpoint, not prevention or diagnostic remission.
2026-09-14 primary-source recheck.
- S44
MamaLift Plus 510(k) K223515: cleared April 22, 2024 ↗Prescription adjunct to clinician-managed outpatient care for adults 22+ with mild/moderate PPD.
2026-09-14 primary-source recheck.
- S45
Internet CBT for Women With Postnatal Depression: MumMoodBooster randomized trial ↗Carried forward from prior research pass; see recorded access scope.
- S46
Internet and Face-to-face CBT for Postnatal Depression Compared With Treatment as Usual ↗Carried forward from prior research pass; see recorded access scope.
- S47
Research and employee services ↗Company-reported results are not independently verified effectiveness estimates.
Carried forward from prior research pass; see recorded access scope.
- S48
Florida Blue expands maternal health and well-being support ↗Primary payer announcement: Canopie launched January 2026 for eligible members.
Carried forward from prior research pass; see recorded access scope.
- S49
National Implementation of Perinatal Mental Health Treatment—The MumSpace Digital Stepped-Care Model ↗Carried forward from prior research pass; see recorded access scope.
- S50
National Maternal Mental Health Hotline ↗Carried forward from prior research pass; see recorded access scope.
- S51
Ellen’s story ↗Individual retrospective account; not representative or a treatment trial.
2026-09-14 primary-source recheck.
- S52
Birth Trauma, by Emma Quick ↗Individual retrospective account; permission would be required for marketing reuse.
2026-09-14 primary-source recheck.
- S53
Health Products Compliance Guidance ↗2026-09-14 primary-source recheck.
- S54
Complying with FTC’s Health Breach Notification Rule ↗Carried forward from prior research pass; see recorded access scope.
- S55
General Wellness: Policy for Low Risk Devices ↗January 2026 guidance; wellness label does not erase disease intended use.
Carried forward from prior research pass; see recorded access scope.
- S56
Spam policies for Google web search ↗Carried forward from prior research pass; see recorded access scope.
- S57
Guidance on generative AI content ↗2026-09-14 primary-source recheck.
- S58
Held postpartum care ↗Adjacent existing brand found; Brighter Postpartum is not trademark-cleared. Do not imply affiliation.
Carried forward from prior research pass; see recorded access scope.
- S59
Held Perinatal ↗Illustrates traditional/holistic service positioning, not proof of efficacy.
Carried forward from prior research pass; see recorded access scope.
- S60
Electroconvulsive therapy in postpartum psychosis: systematic review ↗Small and mostly nonrandomized reports; specialist treatment, not home self-care.
Carried forward from prior research pass; see recorded access scope.
- S61
Draft Recommendation Statement: Perinatal Depression: Interventions to Prevent ↗Draft, not a final recommendation. Includes 21 counseling studies with depression-status outcomes; 2019 final remains listed.
Final pass: original page or abstract rechecked; not a new systematic review.
- S62
Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial ↗Anemia population; three active iron treatments, not placebo or routine supplementation of non-anemic people. Historical comparison not used here.
2026-09-14 extension; original research or institution.
- S63
SAINT in Postpartum Depression (PPD), NCT07210255 ↗Recruiting trial with planned 192 participants; no results reported on this page. Not efficacy evidence.
2026-09-14 extension; original research or institution.
- S64
Treatment of traumatic birth experience with postpartum early eye movement desensitization and reprocessing therapy: a randomized clinical trial ↗151 randomized; 143 in analysis after withdrawals/inaccessibility. PTSD primary outcome; depression secondary. No autonomous trauma processing implied.
2026-09-14 extension; original research or institution.
- S65
Effects of early postpartum massage on physical discomfort, mood, and emotional well-being: A randomized controlled trial ↗112 women after vaginal delivery; excluded psychiatric disorders; immediate mood/discomfort, not prevention of diagnosed depression.
2026-09-14 extension; original research or institution.
- S66
Auricular acupressure with five-element music therapy reduces labor pain and short-term postpartum depression: A randomized controlled trial ↗146 participants; combined intervention during labor; EPDS-based status at one week favored intervention, no significant difference at six weeks.
2026-09-14 extension; original research or institution.
- S67
Effect of singing interventions on symptoms of postnatal depression: three-arm randomised controlled trial ↗134 participants; overall result not statistically significant, with a positive moderate/severe subgroup finding.
Joy-first expansion; selected primary-source retrieval.
- S68
Clinical effectiveness, implementation effectiveness and cost-effectiveness of a community singing intervention for postnatal depressive symptoms, SHAPER-PND ↗199 participants. Later between-group differences; differential attrition and missing-data assumptions limit confidence. DOI resolves to the primary publication.
Joy-first expansion; selected primary-source retrieval.
- S69
Maternal communication and attachment following a group singing intervention for postnatal depression: findings from the SHAPER-PND trial ↗Communication videos available for 100 of the original 199 participants. Same trial as S68, not independent replication.
Joy-first expansion; selected primary-source retrieval.
- S70
How group singing facilitates recovery from the symptoms of postnatal depression: a comparative qualitative study ↗54 participants in ten focus groups. Lived-experience mechanism hypotheses, not causal mediation or independent efficacy testing.
Joy-first expansion; selected primary-source retrieval.
- S71
Relational savoring intervention: Positive impacts for mothers and evidence of cultural compatibility for Latinas ↗Published online May 2022, in 2023 issue. Mothers of toddlers; not a newborn-PPD trial. Overall parenting wellness at three months did not improve.
Joy-first expansion; selected primary-source retrieval.
- S72
Increasing Parental Well-Being After the Neonatal Intensive Care Unit Through Relational Savoring ↗240 US post-NICU parents; immediate pre/post outcomes. Does not establish lasting PPD prevention.
Joy-first expansion; selected primary-source retrieval.
- S73
Positive Affect Treatment for Depression, Anxiety, and Low Positive Affect: A Randomized Clinical Trial ↗98 adults; not perinatal. Fifteen therapist sessions, not a microgame. Composite advantage did not mean superiority on every positive-affect or anhedonia outcome.
Joy-first expansion; selected primary-source retrieval.
- S74
Mamma Mia universal perinatal internet intervention: subjective well-being outcomes ↗Descriptive title. Trial of 1,342 pregnant participants; lower negative affect without improvement in positive affect or life satisfaction.
Joy-first expansion; selected primary-source retrieval.
- S75
Be a Mom: effects on depressive and anxiety symptoms in women at high risk of postpartum depression ↗Descriptive title; 1,053 participants. Large differential attrition; bundled CBT/third-wave program does not isolate self-compassion or prove universal prevention.
Joy-first expansion; selected primary-source retrieval.
- S76
Couple-Focused Prevention at the Transition to Parenthood, a Randomized Trial: Effects on Coparenting, Parenting, Family Violence, and Parent and Child Adjustment ↗399 first-time-parent couples; nine-session Family Foundations program. Not evidence for any one app handoff or for all family structures.
Joy-first expansion; selected primary-source retrieval.
- S77
Compassion-focused therapy for women with postpartum depression: self-esteem, rumination and loneliness outcomes ↗Descriptive title. 48 participants, eight-week group intervention and wait-list comparison. Selected psychological endpoints, not proof of depression remission.
Joy-first expansion; selected primary-source retrieval.
- S78
“just like therapy!”: Investigating the Potential of Storytelling in Online Postpartum Depression Communities ↗Self-reported community experience and design implications, not a clinical trial. Publication status and licensing need checking before reuse.
Joy-first expansion; selected primary-source retrieval.
- S79
The effects of mother-infant singing on emotional closeness, affect, anxiety, and stress hormones ↗43 mothers; immediate outcomes. Does not establish longitudinal PPD benefit or an AI-song effect.
Joy-first expansion; selected primary-source retrieval.
- S80
Qeepsake product and pricing ↗Competitive positioning only. Product pricing can change; no efficacy inference.
Joy-first expansion; selected primary-source retrieval.
- S81
How FamilyAlbum 1s Movies work ↗Existing family montage functionality. Not clinical evidence.
Joy-first expansion; selected primary-source retrieval.
- S82
1 Second Everyday ↗Existing personal video-journal product. Not clinical evidence.
Joy-first expansion; selected primary-source retrieval.
- S83
Finch self-care companion ↗Gameful self-care inspiration. Marketing and features do not establish postpartum efficacy.
Joy-first expansion; selected primary-source retrieval.
- S84
HTMLCanvasElement.captureStream() ↗Browser capability documentation; fallback required when unsupported.
Joy-first expansion; selected primary-source retrieval.
- S85
MediaRecorder.isTypeSupported() ↗Runtime codec detection; supported type alone does not guarantee adequate memory or successful encoding.
Joy-first expansion; selected primary-source retrieval.
- S86
Investigating the Effectiveness of Technology-Based Distal Interventions for Postpartum Depression and Anxiety: Systematic Review and Meta-Analysis ↗Revalidated against the supplied report. Depression favored intervention; social ties did not significantly improve. Distal delivery is not synonymous with autonomous AI.
Final pass: original page or abstract rechecked; not a new systematic review.
- S87
Endocrinology of Pregnancy ↗Hormonal physiology reference, not an intervention trial.
Final consolidation targeted web verification.
- S88
Making breastmilk ↗Prolactin and oxytocin have distinct roles; this does not assign feeding choices.
Final consolidation targeted web verification.
- S89
Postpartum Pain Management ↗Symptoms and recovery vary; not a rigid recovery schedule. Warning-sign thresholds can differ by source; use CDC urgent guidance on our urgent card.
Final consolidation targeted web verification.
- S90
Optimizing Postpartum Care ↗Contact within three weeks and comprehensive visit no later than twelve weeks; earlier care for specific risks/symptoms. Ongoing process, not an all-clear deadline.
Final consolidation targeted web verification.
- S91
Urgent Maternal Warning Signs and Symptoms ↗Urgent symptoms during pregnancy and through the following year. Educational list is not exhaustive.
Final consolidation targeted web verification.
- S92
Neuroanatomical changes observed over the course of a human pregnancy ↗One person, 26 MRI sessions; detailed anatomy is not a population diagnostic test or an intelligence score.
Final consolidation targeted web verification.
- S93
Pregnancy entails a U-shaped trajectory in human brain structure linked to hormones and maternal attachment ↗Observational brain trajectories and associations; no inference of damage, individual outcome, or treatment efficacy.
Final consolidation targeted web verification.
- S94
Longitudinal evidence that fatherhood decreases testosterone in human males ↗624 Filipino men followed over 4.5 years. Not universal day-by-day postpartum hormone values or a testosterone-treatment trial.
Final consolidation targeted web verification.
- S95
Prevalence of paternal depression in pregnancy and the postpartum: An updated meta-analysis ↗Historical pooled estimate with substantial methodological heterogeneity; not a current national surveillance count.
Final consolidation targeted web verification.
- S96
Cognitive household labor: gender disparities and consequences for maternal mental health and wellbeing ↗Online 2024; 322 mothers of young children. Self-report associations, not proof this task app prevents depression.
Final consolidation targeted web verification.
- S97
Preventing postpartum insomnia: CBT-I, responsive bassinet, and sleep hygiene randomized trial ↗127 first-time pregnant participants with insomnia symptoms; primary endpoint insomnia, not universal PPD prevention.
Final consolidation targeted web verification.
- S98
Breastfeeding benefits ↗Plan-specific pump and counseling requirements; grandfathered plans excepted. Confirm suppliers, authorization, and out-of-pocket costs before purchasing.
Final consolidation targeted web verification.
- S99
WIC Eligibility ↗Program determines eligibility; dates, income and nutrition assessment matter. We do not collect benefit documents or decide eligibility.
Final consolidation targeted web verification.
- S100
Your Local 211 ↗Local non-emergency assistance navigation; availability and eligibility differ by area.
Final consolidation targeted web verification.
- S101
Advertise With Us ↗Organization-reported channels. No pricing verified and no partnership with this product.
Final consolidation targeted web verification.
- S102
Choose Joy Nursing: services and founder introduction ↗Provider self-description, not independent outcome evidence. Resources page already advertises an app, care log and chatbot; complement rather than assume no software. No partnership agreed.
Final consolidation targeted web verification.
- S103
Baby 101 Video Course ↗Final original-page fetch displayed $249, while resources displayed $99. Earlier search snippets showed $199. Do not publish a price or discount until the provider confirms checkout. No course content or affiliate rights obtained.
Final consolidation targeted web verification.
- S104
Resources and Baby 101 Video Course listing ↗Final original-page fetch displayed $99 and an existing mobile app with a care log, course content and chatbot. Dedicated course page displayed $249. These are unresolved first-party displays, not an exclusive offer.
Final consolidation targeted web verification.
- S105
FTC Endorsement Guides: What People Are Asking ↗Disclose material connections clearly near the recommendation; affiliate-link jargon alone may be unclear.
Final consolidation targeted web verification.
- S106
Fraud and Abuse Laws ↗Federal Anti-Kickback Statute applies to specified federal-program business; state fee-splitting/referral laws may also apply. No blanket exception for cash-pay or a fixed fee is claimed.
Final consolidation targeted web verification.
- S107
MomCo Membership ↗Local and online meetups and member benefits are organization-reported. Distinguish a local pilot from national endorsement.
Final consolidation targeted web verification.
- S108
Testosterone of young husbands rises with children in the home ↗Different population/design from Gettler; retains conflicting evidence rather than asserting all fathers have low testosterone.
Final consolidation targeted web verification.
- S109
GABA(A)R plasticity during pregnancy: relevance to postpartum depression ↗Mouse receptor-plasticity experiment. Do not convert mouse behavioral findings into human diagnosis, individual prediction or a child-safety forecast.
Prior source record..
- S110
Summary Basis of Decision for Zurzuvae — clinical pharmacology ↗Mechanism is not fully understood; positive allosteric modulation of GABA-A is discussed. Canadian regulatory source used for mechanistic explanation, not US prescribing directions or eligibility.
Prior source record..